Clinicians will collaborate with local physicians, offering patients updated treatment recommendations and access to cutting-edge research.
Originally built in 1975, the Wallace Tumor Institute is the hub of the Comprehensive Cancer Center’s research and administrative enterprise.
On Friday, August 23, 2013, the Comprehensive Cancer Center will officially celebrate the grand opening of the recently renovated Wallace Tumor Institute.
The American Cancer Society is conducting the Cancer Prevention Study-3; enrollment is coming to UAB this fall.
Louise Chow, Ph.D., professor in the Department of Biochemistry and Molecular Genetics and senior scientist at the UAB Comprehensive Cancer Center, was elected a foreign associate of the National Academy of Sciences for excellence in original scientific research.
Biomarkers could tailor preventative or therapeutic aspirin regimens by predicting patients’ response.
The Division of Neurosurgery will become the Department on Oct. 1, 2013, elevating the profile of an already world-renowned program.
In this preliminary analysis, the first human study treatment neither built up in organs nor destroyed the bone marrow’s ability to make blood cells.
Partridge, director of the UAB Comprehensive Cancer Center, was honored by the American Cancer Society for his exceptional talents and his commitment to make progress towards finishing the fight against cancer.
In an engineering feat, the UAB Comprehensive Cancer Center installs a cyclotron unique to academic medical settings.